Luu, Laurence D. W. http://orcid.org/0000-0003-2516-2121
Pandey, Abhimanu http://orcid.org/0000-0002-2367-3422
Paramsothy, Sudarshan http://orcid.org/0000-0002-9097-6028
Ngo, Chinh
Castaño-Rodríguez, Natalia http://orcid.org/0000-0001-8819-8872
Liu, Cheng
Kamm, Michael A.
Borody, Thomas J. http://orcid.org/0000-0002-0519-4698
Man, Si Ming http://orcid.org/0000-0002-5079-2857
Kaakoush, Nadeem O. http://orcid.org/0000-0003-4017-1077
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP2011047, APP2002686)
University of New South Wales
Crohn's and Colitis Foundation (IBD-0391R, 988415)
Crohn's and Colitis Foundation
Australian National University
CSL Centenary Fellowship
Article History
Received: 17 July 2023
Accepted: 15 March 2024
First Online: 26 March 2024
Competing interests
: S.P. has served as a consultant for Finch Therapeutics and has received speaker fees from Ferring, Janssen and Takeda. T.J.B. has a pecuniary interest in the Centre for Digestive Diseases, is a medical advisor to Finch Therapeutics, RedHill Bio and Topelia Aust, and holds patents in FMT treatment. All other authors have no conflicts of interest to declare.